Romain Magnez Email

Responsable laboratoire R&D . Vaxinano

Current Roles

Employees:
17
Revenue:
$2.6M
About
Vaxinano is a clinical-stage biotechnology company, developing a new generation of nasally administered vaccines that are more efficient and faster to deploy to combat infectious diseases and new pandemics. \n\nThe vaccine is based on STELLAR-NP nanoparticles that confer highly stable, adjuvant-free solution for an effective and long-lasting response tot protect against the most difficult pathogens, such as parasites, viruses or bacteria...
Vaxinano Address

Loos, null
FR
Vaxinano Email